Skip to main content
. 2021 Jun 23;224(8):1305–1315. doi: 10.1093/infdis/jiab333

Figure 1.

Figure 1.

A, Detection of anti–SARS-CoV-2 spike 1, S1-RBD, and NP antibodies in convalescent sera from COVID-19 patients (n = 16) as compared to age-matched prepandemic healthy control samples (n = 22). ****P < .0001. Horizontal bars represent geometric mean antibody titers in each group. Dashed lines indicate the antibody positivity cutoff for anti-S1, S1-RBD, and NP IgG antibodies. B, Correlations between the antigen-specific anti–SARS-CoV-2 IgG antibodies to S1, S-RBD, and NP antigens in the convalescent samples (Pearson r = 0.85, 0.86, and 0.78, respectively). Abbreviations: COVID-19, coronavirus disease 2019; IgG, immunoglobulin G; NP, nucleocapsid protein; RBD, receptor-binding domain; S, spike; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.